Global Erythropoietin Drugs Market Size study & Forecast, by Type (Biologics, Biosimilars), by Product (Erythropoietin, Darbepoetin-alfa), by Application (Cancer, Renal Disease, Neurology, Others), and Regional Analysis, 2023-2030

Description

List of Tables

Global Erythropoietin Drugs Market is valued at approximately USD 6.87 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 1.5% during the forecast period 2023-2030. Erythropoietin (EPO), also known as hematopoietin, is a glycoprotein hormone that stimulates the production of red blood cells in the bone marrow, a process known as erythropoiesis. Initially developed to address anemic conditions arising from End-Stage Renal Disease (ESRD) and related treatments such as dialysis, EPO drugs have expanded their applications. Following successful Post-abbreviated New Drug Application (ANDA) approvals, EPO drugs have been increasingly sanctioned for managing chemotherapy-induced anemia. The market growth is driven by key factors such as the rising incidence of chronic diseases and the rising number of CKD cases.

The growth can be attributed to the rising incidence of chronic diseases such as cancer, end-stage renal diseases, HIV, and neurological diseases. As per Statista, the prevalence of individuals experiencing at least two chronic diseases in Italy varied between 2010 and 2022, exhibiting an overall upward trend. In 2018, the peak was observed, with over 12.9 million people affected by at least two chronic diseases. By 2022, approximately 12.6 million Italians were grappling with at least two chronic diseases.. Furthermore, By the year 2050, it is anticipated that this number will surge to approximately 171 million. The prevalence of individuals with chronic conditions in the United States has been on a gradual rise since 1995. This data depicts the count of individuals with chronic medical conditions in the United States spanning from 1995 to 2020, along with projections for 2025 and 2050. However, the launch of alternative drugs and increased demand for EPO Side effects stifle market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Erythropoietin Drugs Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the overall erythropoietin drugs market in terms of the revenue share of XX% in 2022. The regional market is anticipated to significantly benefit from local organizations that are actively engaged in advancing the development and use of erythropoietin drugs. Along with this, Asia Pacific is expected to witness fastest growth with CAGR XX% over the forecast period. The growth of the region is attributed to the presence of key players in the market and strategic initiatives undertaken by them to develop and commercialize new erythropoietin drug products to treat anemia patients.

Major market player included in this report are:

Teva Pharmaceutical Industries Ltd.
Johnson & Johnson Services, Inc.
Intas Pharmaceuticals Ltd.
Novartis AG
Amgen, Inc.
F. Hoffmann-La Roche Ltd.
LG Chem
Biocon
Sun Pharmaceutical Industries Ltd
Dr. Reddy's Laboratories Ltd

Recent Developments in the Market:

In November 2022, Dong-A ST forged a strategic partnership with Polifarma regarding the DA-3880 NESP biosimilar. This collaboration granted Polifarma the right to commercialize and advance the development of DA-3880 in the markets of Brazil, Mexico, and Turkey.
In September 2021, Wanbang Biopharma obtained approval from the National Medical Products Administration (NMPA) for Yi Bao (Human Erythropoietin Injection). This approval signifies its intended use in addressing chemotherapy-related anemia in individuals with non-myeloid malignancies.

Global Erythropoietin Drugs Market Report Scope:

Historical Data - 2020 - 2021
Base Year for Estimation - 2022
Forecast period - 2023-2030
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered - Product, Application, Type, Region
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope - Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

Erythropoietin
Darbepoetin-alfa

By Type:

Biologics
Biosimilars

By Application:

Cancer
Renal Diseases
Neurology
Others

By Region:

North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Chapter 1. Executive Summary

1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
- 1.2.1. Erythropoietin Drugs Market, by Region, 2020-2030 (USD Billion)
- 1.2.2. Erythropoietin Drugs Market, by Type, 2020-2030 (USD Billion)
- 1.2.3. Erythropoietin Drugs Market, by Product, 2020-2030 (USD Billion)
- 1.2.4. Erythropoietin Drugs Market, by Application, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption

Chapter 2. Global Erythropoietin Drugs Market Definition and Scope

2.1. Objective of the Study
2.2. Market Definition & Scope
- 2.2.1. Industry Evolution
- 2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates

Chapter 3. Global Erythropoietin Drugs Market Dynamics

3.1. Erythropoietin Drugs Market Impact Analysis (2020-2030)
- 3.1.1. Market Drivers
  - 3.1.1.1. Rising incidence of chronic diseases
  - 3.1.1.2. Rising number of CKD cases
- 3.1.2. Market Challenges
  - 3.1.2.1. Launch of alternative drugs
  - 3.1.2.2. Increased demand for EPO Side effects
- 3.1.3. Market Opportunities
  - 3.1.3.1. Rise in trends of commercialization for erythropoietin biosimilars
  - 3.1.3.2. Increase in level of awareness regarding benefits of EPO therapeutics

Chapter 4. Global Erythropoietin Drugs Market Industry Analysis

4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
4.2. Porter's 5 Force Impact Analysis
4.3. PEST Analysis
- 4.3.1. Political
- 4.3.2. Economical
- 4.3.3. Social
- 4.3.4. Technological
- 4.3.5. Environmental
- 4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Erythropoietin Drugs Market, by Type

5.1. Market Snapshot
5.2. Global Erythropoietin Drugs Market by Type, Performance - Potential Analysis
5.3. Global Erythropoietin Drugs Market Estimates & Forecasts by Type 2020-2030 (USD Billion)
5.4. Erythropoietin Drugs Market, Sub Segment Analysis
- 5.4.1. Biologics
- 5.4.2. Biosimilars

Chapter 6. Global Erythropoietin Drugs Market, by Product

6.1. Market Snapshot
6.2. Global Erythropoietin Drugs Market by Product, Performance - Potential Analysis
6.3. Global Erythropoietin Drugs Market Estimates & Forecasts by Product 2020-2030 (USD Billion)
6.4. Erythropoietin Drugs Market, Sub Segment Analysis
- 6.4.1. Erythropoietin
- 6.4.2. Darbepoetin-alfa

Chapter 7. Global Erythropoietin Drugs Market, by Application

7.1. Market Snapshot
7.2. Global Erythropoietin Drugs Market by Application, Performance - Potential Analysis
7.3. Global Erythropoietin Drugs Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
7.4. Erythropoietin Drugs Market, Sub Segment Analysis
- 7.4.1. Cancer
- 7.4.2. Renal Diseases
- 7.4.3. Neurology
- 7.4.4. Others

Chapter 8. Global Erythropoietin Drugs Market, Regional Analysis

8.1. Top Leading Countries
8.2. Top Emerging Countries
8.3. Erythropoietin Drugs Market, Regional Market Snapshot
8.4. North America Erythropoietin Drugs Market
- 8.4.1. U.S. Erythropoietin Drugs Market
  - 8.4.1.1. Type breakdown estimates & forecasts, 2020-2030
  - 8.4.1.2. Product breakdown estimates & forecasts, 2020-2030
  - 8.4.1.3. Application breakdown estimates & forecasts, 2020-2030
- 8.4.2. Canada Erythropoietin Drugs Market
8.5. Europe Erythropoietin Drugs Market Snapshot
- 8.5.1. U.K. Erythropoietin Drugs Market
- 8.5.2. Germany Erythropoietin Drugs Market
- 8.5.3. France Erythropoietin Drugs Market
- 8.5.4. Spain Erythropoietin Drugs Market
- 8.5.5. Italy Erythropoietin Drugs Market
- 8.5.6. Rest of Europe Erythropoietin Drugs Market
8.6. Asia-Pacific Erythropoietin Drugs Market Snapshot
- 8.6.1. China Erythropoietin Drugs Market
- 8.6.2. India Erythropoietin Drugs Market
- 8.6.3. Japan Erythropoietin Drugs Market
- 8.6.4. Australia Erythropoietin Drugs Market
- 8.6.5. South Korea Erythropoietin Drugs Market
- 8.6.6. Rest of Asia Pacific Erythropoietin Drugs Market
8.7. Latin America Erythropoietin Drugs Market Snapshot
- 8.7.1. Brazil Erythropoietin Drugs Market
- 8.7.2. Mexico Erythropoietin Drugs Market
8.8. Middle East & Africa Erythropoietin Drugs Market
- 8.8.1. Saudi Arabia Erythropoietin Drugs Market
- 8.8.2. South Africa Erythropoietin Drugs Market
- 8.8.3. Rest of Middle East & Africa Erythropoietin Drugs Market

Chapter 9. Competitive Intelligence

9.1. Key Company SWOT Analysis
- 9.1.1. Company 1
- 9.1.2. Company 2
- 9.1.3. Company 3
9.2. Top Market Strategies
9.3. Company Profiles
- 9.3.1. Teva Pharmaceutical Industries Ltd.
  - 9.3.1.1. Key Information
  - 9.3.1.2. Overview
  - 9.3.1.3. Financial (Subject to Data Availability)
  - 9.3.1.4. Product Summary
  - 9.3.1.5. Recent Developments
- 9.3.2. Johnson & Johnson Services, Inc.
- 9.3.3. Intas Pharmaceuticals Ltd.
- 9.3.4. Novartis AG
- 9.3.5. Amgen, Inc.
- 9.3.6. F. Hoffmann-La Roche Ltd.
- 9.3.7. LG Chem
- 9.3.8. Biocon
- 9.3.9. Sun Pharmaceutical Industries Ltd
- 9.3.10. Dr. Reddy's Laboratories Ltd

Chapter 10. Research Process

10.1. Research Process
- 10.1.1. Data Mining
- 10.1.2. Analysis
- 10.1.3. Market Estimation
- 10.1.4. Validation
- 10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

LIST OF TABLES

TABLE 1. Global Erythropoietin Drugs Market, report scope
TABLE 2. Global Erythropoietin Drugs Market estimates & forecasts by Region 2020-2030 (USD Billion)
TABLE 3. Global Erythropoietin Drugs Market estimates & forecasts by Type 2020-2030 (USD Billion)
TABLE 4. Global Erythropoietin Drugs Market estimates & forecasts by Product 2020-2030 (USD Billion)
TABLE 5. Global Erythropoietin Drugs Market estimates & forecasts by Application 2020-2030 (USD Billion)
TABLE 6. Global Erythropoietin Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 7. Global Erythropoietin Drugs Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 8. Global Erythropoietin Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 9. Global Erythropoietin Drugs Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 10. Global Erythropoietin Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 11. Global Erythropoietin Drugs Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 12. Global Erythropoietin Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 13. Global Erythropoietin Drugs Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 14. Global Erythropoietin Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 15. Global Erythropoietin Drugs Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 16. U.S. Erythropoietin Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 17. U.S. Erythropoietin Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 18. U.S. Erythropoietin Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 19. Canada Erythropoietin Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 20. Canada Erythropoietin Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 21. Canada Erythropoietin Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 22. UK Erythropoietin Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 23. UK Erythropoietin Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 24. UK Erythropoietin Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 25. Germany Erythropoietin Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 26. Germany Erythropoietin Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 27. Germany Erythropoietin Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 28. France Erythropoietin Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 29. France Erythropoietin Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 30. France Erythropoietin Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 31. Italy Erythropoietin Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 32. Italy Erythropoietin Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 33. Italy Erythropoietin Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 34. Spain Erythropoietin Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 35. Spain Erythropoietin Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 36. Spain Erythropoietin Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 37. RoE Erythropoietin Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 38. RoE Erythropoietin Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 39. RoE Erythropoietin Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 40. China Erythropoietin Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 41. China Erythropoietin Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 42. China Erythropoietin Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 43. India Erythropoietin Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 44. India Erythropoietin Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 45. India Erythropoietin Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 46. Japan Erythropoietin Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 47. Japan Erythropoietin Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 48. Japan Erythropoietin Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 49. South Korea Erythropoietin Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 50. South Korea Erythropoietin Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 51. South Korea Erythropoietin Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 52. Australia Erythropoietin Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 53. Australia Erythropoietin Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 54. Australia Erythropoietin Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 55. RoAPAC Erythropoietin Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 56. RoAPAC Erythropoietin Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 57. RoAPAC Erythropoietin Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 58. Brazil Erythropoietin Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 59. Brazil Erythropoietin Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 60. Brazil Erythropoietin Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 61. Mexico Erythropoietin Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 62. Mexico Erythropoietin Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 63. Mexico Erythropoietin Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 64. RoLA Erythropoietin Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 65. RoLA Erythropoietin Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 66. RoLA Erythropoietin Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 67. Saudi Arabia Erythropoietin Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 68. South Africa Erythropoietin Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 69. RoMEA Erythropoietin Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 70. List of secondary sources, used in the study of global Erythropoietin Drugs Market
TABLE 71. List of primary sources, used in the study of global Erythropoietin Drugs Market
TABLE 72. Years considered for the study
TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

FIG 1. Global Erythropoietin Drugs Market, research methodology
FIG 2. Global Erythropoietin Drugs Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Erythropoietin Drugs Market, key trends 2022
FIG 5. Global Erythropoietin Drugs Market, growth prospects 2023-2030
FIG 6. Global Erythropoietin Drugs Market, porters 5 force model
FIG 7. Global Erythropoietin Drugs Market, pest analysis
FIG 8. Global Erythropoietin Drugs Market, value chain analysis
FIG 9. Global Erythropoietin Drugs Market by segment, 2020 & 2030 (USD Billion)
FIG 10. Global Erythropoietin Drugs Market by segment, 2020 & 2030 (USD Billion)
FIG 11. Global Erythropoietin Drugs Market by segment, 2020 & 2030 (USD Billion)
FIG 12. Global Erythropoietin Drugs Market by segment, 2020 & 2030 (USD Billion)
FIG 13. Global Erythropoietin Drugs Market by segment, 2020 & 2030 (USD Billion)
FIG 14. Global Erythropoietin Drugs Market, regional snapshot 2020 & 2030
FIG 15. North America Erythropoietin Drugs Market 2020 & 2030 (USD Billion)
FIG 16. Europe Erythropoietin Drugs Market 2020 & 2030 (USD Billion)
FIG 17. Asia pacific Erythropoietin Drugs Market 2020 & 2030 (USD Billion)
FIG 18. Latin America Erythropoietin Drugs Market 2020 & 2030 (USD Billion)
FIG 19. Middle East & Africa Erythropoietin Drugs Market 2020 & 2030 (USD Billion)